Pôle Est, Centre Hospitalier Le Vinatier, Bron, France.
INSERM U1028; CNRS UMR5292; PSYR2 Team; Lyon Neuroscience Research Center, Université Claude Bernard Lyon 1, Université Jean Monnet, Lyon, France.
Schizophr Bull. 2022 Nov 18;48(6):1284-1294. doi: 10.1093/schbul/sbac078.
Impaired insight into the illness and its consequences is associated with poor outcomes in schizophrenia. While transcranial direct current stimulation (tDCS) may represent a potentially effective treatment strategy to relieve various symptoms of schizophrenia, its impact on insight remains unclear. To investigate whether tDCS would modulate insight in patients with schizophrenia, we undertook a meta-analysis based on results from previous RCTs that investigated the clinical efficacy of tDCS. We hypothesize that repeated sessions of tDCS will be associated with insight improvement among patients.
PubMed and ScienceDirect databases were systematically searched to identify RCTs that delivered at least 10 tDCS sessions in patients with schizophrenia. The primary outcome was the change in insight score, assessed by the Positive and Negative Syndrome Scale (PANSS) item G12 following active tDCS sessions as opposed to sham stimulation. Effect sizes were calculated for all studies and pooled using a random-effects model. Meta-regression and subgroup analyses were conducted.
Thirteen studies (587 patients with schizophrenia) were included. A significant pooled effect size (g) of -0.46 (95% CI [-0.78; -0.14]) in favor of active tDCS was observed. Age and G12 score at baseline were identified as significant moderators, while change in total PANSS score was not significant.
Ten sessions of active tDCS with either frontotemporoparietal or bifrontal montage may improve insight into the illness in patients with schizophrenia. The effect of this treatment could contribute to the beneficial outcomes observed in patients following stimulation.
对疾病及其后果缺乏洞察力与精神分裂症的不良结局相关。虽然经颅直流电刺激(tDCS)可能代表一种有效的治疗策略,可以缓解精神分裂症的各种症状,但它对洞察力的影响尚不清楚。为了研究 tDCS 是否会调节精神分裂症患者的洞察力,我们根据之前研究 tDCS 临床疗效的 RCT 结果进行了一项荟萃分析。我们假设重复 tDCS 治疗会与患者洞察力的提高相关。
系统地检索了 PubMed 和 ScienceDirect 数据库,以确定在精神分裂症患者中至少进行了 10 次 tDCS 治疗的 RCT。主要结果是阳性和阴性综合征量表(PANSS)项目 G12 的洞察力评分变化,与假刺激相比,在积极的 tDCS 治疗后进行评估。对所有研究进行了效应量计算,并使用随机效应模型进行了合并。进行了元回归和亚组分析。
共纳入 13 项研究(587 例精神分裂症患者)。观察到积极 tDCS 具有显著的合并效应大小(g)为-0.46(95%置信区间[-0.78;-0.14])。年龄和基线时的 G12 评分被确定为显著的调节因素,而总 PANSS 评分的变化则不显著。
采用额颞顶或双额导联进行 10 次积极 tDCS 治疗可能会改善精神分裂症患者对疾病的洞察力。这种治疗的效果可能有助于刺激后患者的良好结局。